These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10331568)

  • 1. Role of p53 gene mutation in tumor aggressiveness of intracranial meningiomas.
    Cho H; Ha SY; Park SH; Park K; Chae YS
    J Korean Med Sci; 1999 Apr; 14(2):199-205. PubMed ID: 10331568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of TP53 gene mutation in human meningiomas: a study using immunohistochemistry, polymerase chain reaction/single-strand conformation polymorphism and DNA sequencing techniques on paraffin-embedded samples.
    Wang JL; Zhang ZJ; Hartman M; Smits A; Westermark B; Muhr C; Nistér M
    Int J Cancer; 1995 Aug; 64(4):223-8. PubMed ID: 7657383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 point mutation is rare in meningiomas from Singaporean patients.
    Das A; Tan WL; Smith DR
    Asian J Surg; 2005 Jan; 28(1):7-10. PubMed ID: 15691789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P53 overexpression and proliferative potential in malignant meningiomas.
    Nagashima G; Aoyagi M; Yamamoto M; Yamamoto S; Wakimoto H; Ohno K; Yamamoto K; Hirakawa K
    Acta Neurochir (Wien); 1999; 141(1):53-61; discussion 60-1. PubMed ID: 10071687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 and PCNA expression in benign, atypical and malignant meningiomas.
    Ahmed R; Soomro IN; Aziz SA; Hasan SH
    J Pak Med Assoc; 1999 Oct; 49(10):241-3. PubMed ID: 10647228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and gene doses changes of the p53-regulator PPM1D in meningiomas: a role in meningioma progression?
    Fukami S; Riemenschneider MJ; Kohno M; Steiger HJ
    Brain Tumor Pathol; 2016 Jul; 33(3):191-9. PubMed ID: 26942600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [PCR-SSCP analysis of p53 gene in human primary brain tumor].
    Tan D; Sun Z
    Hua Xi Yi Ke Da Xue Xue Bao; 1997 Mar; 28(1):45-9. PubMed ID: 10684061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of p53, MDM2 protein and Ki-67 antigen in recurrent meningiomas.
    Ohkoudo M; Sawa H; Hara M; Saruta K; Aiso T; Ohki R; Yamamoto H; Maemura E; Shiina Y; Fujii M; Saito I
    J Neurooncol; 1998 May; 38(1):41-9. PubMed ID: 9540056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation of p14(ARF) gene in meningiomas and its correlation to the p53 expression and mutation.
    Amatya VJ; Takeshima Y; Inai K
    Mod Pathol; 2004 Jun; 17(6):705-10. PubMed ID: 15073599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products.
    Mashiyama S; Murakami Y; Yoshimoto T; Sekiya T; Hayashi K
    Oncogene; 1991 Aug; 6(8):1313-8. PubMed ID: 1886708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
    Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
    APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mutations of p53 gene in 41 cases of human brain gliomas].
    Cui W; Kong X; Cao HL; Wang X; Gao JF; Wu RL; Wang XC
    Ai Zheng; 2008 Jan; 27(1):8-11. PubMed ID: 18184456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings.
    Al-Mefty O; Kadri PA; Pravdenkova S; Sawyer JR; Stangeby C; Husain M
    J Neurosurg; 2004 Aug; 101(2):210-8. PubMed ID: 15309910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical evaluation of erbB-2 and p53 protein expression in benign and atypical human meningiomas.
    Chozick BS; Benzil DL; Stopa EG; Pezzullo JC; Knuckey NW; Epstein MH; Finkelstein SD; Finch PW
    J Neurooncol; 1996 Feb; 27(2):117-26. PubMed ID: 8699233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up.
    Lanzafame S; Torrisi A; Barbagallo G; Emmanuele C; Alberio N; Albanese V
    Pathol Res Pract; 2000; 196(7):483-8. PubMed ID: 10926326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas.
    Amatya VJ; Takeshima Y; Sugiyama K; Kurisu K; Nishisaka T; Fukuhara T; Inai K
    Hum Pathol; 2001 Sep; 32(9):970-5. PubMed ID: 11567227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [P53 protein expression and proliferative potential in non-recurrent and recurrent meningiomas].
    Miyagami M; Kanou T; Nakamura S
    No To Shinkei; 1996 Aug; 48(8):719-25. PubMed ID: 8797205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 immunoreactivity and single-strand conformational polymorphism analysis often fail to predict p53 mutational status.
    Tolbert DM; Noffsinger AE; Miller MA; DeVoe GW; Stemmermann GN; Macdonald JS; Fenoglio-Preiser CM
    Mod Pathol; 1999 Jan; 12(1):54-60. PubMed ID: 9950163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas.
    Ozen O; Demirhan B; Altinörs N
    Clin Neuropathol; 2005; 24(5):219-24. PubMed ID: 16167545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of fatty acid metabolism-associated proteins is correlated with the prognosis of meningiomas.
    Jiang J; Lin C; Liu N; Zhang Z; Sun Y; Fang X; Qi J
    APMIS; 2013 Oct; 121(10):997-1003. PubMed ID: 23879478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.